Evans syndrome is characterized by immunized thrombocytopenia and autoimmune haemolytic anaemia. Autoimmune haemolytic anaemia is a condition in which the red globules which carry oxygen and carbon dioxide normally are destroyed by an autoimmune process. Evans syndrome assigns people of all the ages but is usually first diagnosed in the infants. Individually, the immunized thrombocytopaenia and autoimmune haemolytic anaemia assign people of all the ethnic groups but the syndrome of evans can assign the white people more than other ethnic groups. The causes of evan's syndrome is genetic.

Between 5 % to 8% of Americans, up to 23.5 million, have the one or more autoimmune disease. The autoimmune disease occurs among women three times more often than they occur at the men. Some autoimmune diseases are to occur in the children. The syndrome of Evan is rare, serious, and has a reported rate of mortality of 7%. There are many approaches of treatment for the syndrome of Evans. The treatment implies the drug (steroids or the other immunosuppressive ones) and probably the surgical operation such as a splenectomy. Some drugs of chemotherapy can be employed to decline the immune system, as well.

Romiplostimmay can be given into intravenous to help the body to produce plates. The surgical splenectomy is also employed in certain cases. The intravenous immunized globuline or the IVIG is often tested just as chemotherapy when the answers to other treatments are not satisfactory. Children with the need for syndrome for being supervised carefully after a splenectomy as there seems to be a greater risk of sepsis in some children.

Get information on rare diseases and disorders with latest health care treatment.